Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 50

    1.

    Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin).

    Algvere PV, von Wendt G, Gudmundsson J, Seregard S, Kvanta A.

    Acta Ophthalmol. 2009 Nov 7. [Epub ahead of print]PMID: 19900206 [PubMed - as supplied by publisher]Related articles

    2.

    Biomechanical regulation of blood vessel growth during tissue vascularization.

    Kilarski WW, Samolov B, Petersson L, Kvanta A, Gerwins P.

    Nat Med. 2009 Jun;15(6):657-64.PMID: 19483693 [PubMed - indexed for MEDLINE]Related articles

    3.

    Delayed neovascularization in inflammation-induced corneal neovascularization in interleukin-10-deficient mice.

    Samolov B, Kvanta A, van der Ploeg I.

    Acta Ophthalmol. 2008 Nov 25. [Epub ahead of print]PMID: 19053961 [PubMed - as supplied by publisher]Related articles

    4.

    Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.

    Economou MA, Wu J, Vasilcanu D, Rosengren L, All-Ericsson C, van der Ploeg I, Menu E, Girnita L, Axelson M, Larsson O, Seregard S, Kvanta A.

    Acta Ophthalmol. 2008 Nov;86 Thesis 4:42-9.PMID: 19032681 [PubMed - indexed for MEDLINE]Related articles

    5.

    Neovascular age-related macular degeneration: too many theories, too little knowledge?

    Kvanta A.

    Acta Ophthalmol. 2008 Aug;86(5):468-9. No abstract available. PMID: 18752524 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.

    Economou MA, Wu J, Vasilcanu D, Rosengren L, All-Ericsson C, van der Ploeg I, Menu E, Girnita L, Axelson M, Larsson O, Seregard S, Kvanta A.

    Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2620-6.PMID: 18515591 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Shall we use Avastin or Lucentis for ocular neovascularization?

    Algvere PV, Kvanta A, Seregard S.

    Acta Ophthalmol. 2008 Jun;86(4):352-5. No abstract available. PMID: 18498548 [PubMed - indexed for MEDLINE]Related articles

    8.

    A prospective randomised study on low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration.

    Odergren A, Algvere PV, Seregard S, Kvanta A.

    Br J Ophthalmol. 2008 Jun;92(6):757-61. Epub 2008 Mar 20.PMID: 18356266 [PubMed - indexed for MEDLINE]Related articles

    9.

    Involvement of purinergic P2 receptors in experimental retinal neovascularization.

    Sarman S, Mancini J, van der Ploeg I, Croxatto JO, Kvanta A, Gallo JE.

    Curr Eye Res. 2008 Mar;33(3):285-91.PMID: 18350440 [PubMed - indexed for MEDLINE]Related articles

    10.

    A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.

    Algvere PV, Steén B, Seregard S, Kvanta A.

    Acta Ophthalmol. 2008 Aug;86(5):482-9. Epub 2007 Dec 14.PMID: 18162062 [PubMed - indexed for MEDLINE]Related articles

    11.

    Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo.

    Levchenko T, Veitonmäki N, Lundkvist A, Gerhardt H, Ming Y, Berggren K, Kvanta A, Carlsson R, Holmgren L.

    FASEB J. 2008 Mar;22(3):880-9. Epub 2007 Nov 5.PMID: 17984175 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Angiomotin regulates endothelial cell migration during embryonic angiogenesis.

    Aase K, Ernkvist M, Ebarasi L, Jakobsson L, Majumdar A, Yi C, Birot O, Ming Y, Kvanta A, Edholm D, Aspenström P, Kissil J, Claesson-Welsh L, Shimono A, Holmgren L.

    Genes Dev. 2007 Aug 15;21(16):2055-68.PMID: 17699752 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Preoperative sub-Tenon's capsule injection of ropivacaine in conjunction with general anesthesia in retinal detachment surgery.

    Bergman L, Bäckmark I, Ones H, von Euler C, Olivestedt G, Kvanta A, Stéen B, Seregard S, Nilsson B, Berglin L.

    Ophthalmology. 2007 Nov;114(11):2055-60. Epub 2007 Apr 18.PMID: 17445898 [PubMed - indexed for MEDLINE]Related articles

    14.

    New treatments for neovascular age-related macular degeneration: when should we use them?

    Kvanta A.

    Acta Ophthalmol Scand. 2007 Feb;85(1):5. No abstract available. PMID: 17244203 [PubMed - indexed for MEDLINE]Related articles

    15.

    Photodynamic therapy of experimental choroidal neovascularization in the mouse.

    Odergren A, Ming Y, Kvanta A.

    Curr Eye Res. 2006 Sep;31(9):765-74.PMID: 16966149 [PubMed - indexed for MEDLINE]Related articles

    16.

    Ocular angiogenesis: the role of growth factors.

    Kvanta A.

    Acta Ophthalmol Scand. 2006 Jun;84(3):282-8. Review.PMID: 16704684 [PubMed - indexed for MEDLINE]Related articles

    17.

    Choroidal biopsies for intraocular tumors of indeterminate origin.

    Kvanta A, Seregard S, Kopp ED, All-Ericsson C, Landau I, Berglin L.

    Am J Ophthalmol. 2005 Dec;140(6):1002-6.PMID: 16376642 [PubMed - indexed for MEDLINE]Related articles

    18.

    Retinal vascular development and pathologic retinal angiogenesis are not impaired in matrix metalloproteinase-2 deficient mice.

    Sarman S, van der Ploeg I, Seregard S, Kvanta A.

    Curr Eye Res. 2005 Apr;30(4):259-67.PMID: 15823918 [PubMed - indexed for MEDLINE]Related articles

    19.

    Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice.

    Samolov B, Steen B, Seregard S, van der Ploeg I, Montan P, Kvanta A.

    Exp Eye Res. 2005 Feb;80(2):159-66.PMID: 15670794 [PubMed - indexed for MEDLINE]Related articles

    20.

    Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina.

    Ming Y, Algvere PV, Odergren A, Berglin L, van der Ploeg I, Seregard S, Kvanta A.

    Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1969-74.PMID: 15161865 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    TIMP-3 mRNA is not overexpressed in Sorsby fundus dystrophy.

    Chong NH, Kvanta A, Seregard S, Bird AC, Luthert PJ, Steen B.

    Am J Ophthalmol. 2003 Nov;136(5):954-5.PMID: 14597066 [PubMed - indexed for MEDLINE]Related articles

    22.

    Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice.

    Berglin L, Sarman S, van der Ploeg I, Steen B, Ming Y, Itohara S, Seregard S, Kvanta A.

    Invest Ophthalmol Vis Sci. 2003 Jan;44(1):403-8.PMID: 12506102 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Structure and function of the N-cadherin/catenin complex in retinoblastoma.

    Van Aken EH, Papeleu P, De Potter P, Bruyneel E, Philippé J, Seregard S, Kvanta A, De Laey JJ, Mareel MM.

    Invest Ophthalmol Vis Sci. 2002 Mar;43(3):595-602.PMID: 11867572 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    The Swedish national survey of surgical excision for submacular choroidal neovascularization (CNV).

    Berglin L, Algvere P, Olivestedt G, Crafoord S, Stenkula S, Hansson LJ, Tomic Z, Kvanta A, Seregard S.

    Acta Ophthalmol Scand. 2001 Dec;79(6):580-4.PMID: 11782223 [PubMed - indexed for MEDLINE]Related articles

    25.

    Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization.

    Kvanta A, Shen WY, Sarman S, Seregard S, Steen B, Rakoczy E.

    Curr Eye Res. 2000 Sep;21(3):684-90.PMID: 11120556 [PubMed - indexed for MEDLINE]Related articles

    26.

    Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.

    Kvanta A, Sarman S, Fagerholm P, Seregard S, Steen B.

    Exp Eye Res. 2000 Apr;70(4):419-28.PMID: 10865990 [PubMed - indexed for MEDLINE]Related articles

    27.

    Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.

    Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A.

    Invest Ophthalmol Vis Sci. 1998 Oct;39(11):2194-200.PMID: 9761302 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Localization of adenosine receptor messenger RNAs in the rat eye.

    Kvanta A, Seregard S, Sejersen S, Kull B, Fredholm BB.

    Exp Eye Res. 1997 Nov;65(5):595-602.PMID: 9367639 [PubMed - indexed for MEDLINE]Related articles

    29.

    [Gene causing vision impairment among the elderly is discovered]

    Kvanta A, Olivestedt G.

    Lakartidningen. 1997 Nov 12;94(46):4213-4. Review. Swedish. No abstract available. PMID: 9424508 [PubMed - indexed for MEDLINE]Related articles

    30.

    Beta-amyloid protein protein precursor expression in lacrimal glands and tear fluid.

    Van Setten GB, Nilsson L, Hahne S, Johnston JA, Kvanta A, Gandy SE, Näslund J, Nordstedt C.

    Invest Ophthalmol Vis Sci. 1996 Dec;37(13):2585-93.PMID: 8977472 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma.

    Kvanta A, Steen B, Seregard S.

    Exp Eye Res. 1996 Nov;63(5):511-8.PMID: 8994354 [PubMed - indexed for MEDLINE]Related articles

    32.

    Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor.

    Kvanta A, Algvere PV, Berglin L, Seregard S.

    Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1929-34.PMID: 8759365 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts.

    Kvanta A.

    Curr Eye Res. 1995 Nov;14(11):1015-20.PMID: 8585929 [PubMed - indexed for MEDLINE]Related articles

    34.

    [Vascular endothelial growth factor. A vascular growth factor of high specificity]

    Kvanta A.

    Lakartidningen. 1995 Apr 26;92(17):1765-6. Review. Swedish. PMID: 7731318 [PubMed - indexed for MEDLINE]Related articles

    36.

    Synergistic effects between protein kinase C and cAMP on activator protein-1 activity and differentiation of PC-12 pheochromocytoma cells.

    Kvanta A, Fredholm BB.

    J Mol Neurosci. 1993 Winter;4(4):205-14.PMID: 7917831 [PubMed - indexed for MEDLINE]Related articles

    37.

    Activation of protein kinase C and elevation of cAMP interact synergistically to raise c-Fos and AP-1 activity in Jurkat cells.

    Kontny E, Kvanta A, Fredholm BB.

    Eur J Pharmacol. 1992 Nov 2;227(3):333-8.PMID: 1335418 [PubMed - indexed for MEDLINE]Related articles

    38.

    Mitogen stimulation of T-cells increases c-Fos and c-Jun protein levels, AP-1 binding and AP-1 transcriptional activity.

    Kvanta A, Kontny E, Jondal M, Okret S, Fredholm BB.

    Cell Signal. 1992 May;4(3):275-86.PMID: 1510878 [PubMed - indexed for MEDLINE]Related articles

    39.

    Further evidence that propentofylline (HWA 285) influences both adenosine receptors and adenosine transport.

    Fredholm BB, Fastbom J, Kvanta A, Gerwins P, Parkinson F.

    Fundam Clin Pharmacol. 1992;6(3):99-111.PMID: 1628877 [PubMed - indexed for MEDLINE]Related articles

    40.

    Role of a pertussis toxin sensitive G-protein in mediating the effects of phorbol esters on receptor activated cyclic AMP accumulation in Jurkat cells.

    van der Ploeg I, Altiok N, Kvanta A, Nordstedt C, Fredholm BB.

    Naunyn Schmiedebergs Arch Pharmacol. 1991 Nov;344(5):611-7.PMID: 1667331 [PubMed - indexed for MEDLINE]Related articles

    41.

    CD3-dependent increase in cyclic AMP in human T-cells following stimulation of the CD2 receptor.

    Kvanta A, Jondal M, Fredholm BB.

    Biochim Biophys Acta. 1991 Jul 10;1093(2-3):178-83.PMID: 1677813 [PubMed - indexed for MEDLINE]Related articles

    42.

    Translocation of the alpha- and beta-isoforms of protein kinase C following activation of human T-lymphocytes.

    Kvanta A, Jondal M, Fredholm BB.

    FEBS Lett. 1991 Jun 3;283(2):321-4.PMID: 2044773 [PubMed - indexed for MEDLINE]Related articles

    43.

    Stimulation of the T-cell receptors CD3 and CD2 with OKT3 and OKT11 antibodies activates a common pertussis toxin-insensitive G-protein.

    Kvanta A, Gerwins P, van der Ploeg I, Nordstedt C, Jondal M, Fredholm BB.

    Eur J Pharmacol. 1990 Dec 15;189(6):363-72.PMID: 1981560 [PubMed - indexed for MEDLINE]Related articles

    44.

    Evidence that protein kinase C activation is essential for killing by IL-2-activated lymphocytes.

    Kvanta A, Nordstedt C, Fredholm B, Gullberg M, Jondal M.

    Scand J Immunol. 1990 Jan;31(1):103-8.PMID: 2300789 [PubMed - indexed for MEDLINE]Related articles

    45.

    Stimulation of T-cells with OKT3 antibodies increases forskolin binding and cyclic AMP accumulation.

    Kvanta A, Gerwins P, Jondal M, Fredholm BB.

    Cell Signal. 1990;2(5):461-70.PMID: 2177619 [PubMed - indexed for MEDLINE]Related articles

    46.

    Activation of protein kinase C via the T-cell receptor complex potentiates cyclic AMP responses in T-cells.

    Kvanta A, Nordstedt C, Jondal M, Fredholm BB.

    Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6 Pt 2):715-7.PMID: 2561306 [PubMed - indexed for MEDLINE]Related articles

    47.

    CD3/T-cell receptor coupling to a pertussis and cholera toxin-insensitive G-protein.

    Kvanta A, Nordstedt C, van der Ploeg I, Jondal M, Fredholm BB.

    FEBS Lett. 1989 Jul 3;250(2):536-40.PMID: 2526752 [PubMed - indexed for MEDLINE]Related articles

    48.

    [Cytokines in clinical medicine]

    Nordstedt C, Kvanta A, Holm G.

    Lakartidningen. 1989 Mar 8;86(10):834, 836, 838. Review. Swedish. No abstract available. PMID: 2466182 [PubMed - indexed for MEDLINE]Related articles

    49.

    Dual effects of protein kinase-C on receptor-stimulated cAMP accumulation in a human T-cell leukemia line.

    Nordstedt C, Kvanta A, Van der Ploeg I, Fredholm BB.

    Eur J Pharmacol. 1989 Mar 7;172(1):51-60.PMID: 2540999 [PubMed - indexed for MEDLINE]Related articles

    50.

    Agonist but not phorbol ester induced desensitization of human lymphocyte prostaglandin receptor is dependent on tubulin polymerization.

    Nordstedt C, Kvanta A, Fredholm BB.

    Biochem Biophys Res Commun. 1988 Dec 30;157(3):1046-50.PMID: 2849928 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...